静脉-静脉体外膜氧合、俯卧位通气与仰卧位机械通气治疗重度低氧性急性呼吸窘迫综合征的比较:一项网状Meta分析
该网状Meta分析纳入10项随机对照试验、812例重度ARDS(PaO2/FiO2<80 mmHg或符合VV-ECMO入选标准)患者,比较低潮气量、中等潮气量、俯卧位通气与VV-ECMO对死亡率的影响。VV-ECMO较低潮气量(RR 0.77,95%CI 0.59-0.99,中等确定性)和中等潮气量(RR 0.75,95%CI 0.57-0.98,低确定性)降低死亡率;俯卧位通气较中等潮气量(RR 0.78,95%CI 0.66-0.93,高确定性)和低潮气量(RR 0.81,95%CI 0.63-1.02,中等确定性)降低死亡率。VV-ECMO与俯卧位通气比较无差异(RR 0.95,95%CI 0.72-1.26),但仅基于间接比较且确定性极低。
要点
- 重度ARDS(PaO2/FiO2<80 mmHg)成人中,俯卧位通气较中等潮气量通气降低死亡率(RR 0.78,95%CI 0.66-0.93,高确定性)。
- VV-ECMO较低潮气量通气降低死亡率(RR 0.77,95%CI 0.59-0.99,中等确定性),较中等潮气量通气降低死亡率(RR 0.75,95%CI 0.57-0.98,低确定性)。
- 俯卧位通气较低潮气量通气降低死亡率(RR 0.81,95%CI 0.63-1.02,中等确定性)。
- VV-ECMO与俯卧位通气比较无差异(RR 0.95,95%CI 0.72-1.26),仅基于间接比较,确定性极低,置信区间很宽。
适用人群与场景
- 患有重度ARDS且符合VV-ECMO入选标准或PaO2/FiO2<80 mmHg的成人患者。
诊断标准与关键阈值
- 重度ARDS定义为PaO2/FiO2<80 mmHg。
研究设计与关键结果
- 研究类型:随机对照试验的网状Meta分析(频率学派),采用GRADE方法评估证据确定性。
- 纳入10项RCT,共812例重度ARDS患者。
- VV-ECMO较低潮气量通气降低死亡率(RR 0.77,95%CI 0.59-0.99,中等确定性)。
- VV-ECMO较中等潮气量通气降低死亡率(RR 0.75,95%CI 0.57-0.98,低确定性)。
- 俯卧位通气较中等潮气量通气降低死亡率(RR 0.78,95%CI 0.66-0.93,高确定性)。
- 俯卧位通气较低潮气量通气降低死亡率(RR 0.81,95%CI 0.63-1.02,中等确定性)。
- VV-ECMO与俯卧位通气比较无差异(RR 0.95,95%CI 0.72-1.26),仅基于间接比较,确定性极低。
证据类型、等级与局限
- 证据类型:随机对照试验的网状Meta分析。
- 证据确定性按GRADE分级:VV-ECMO较低潮气量为中等确定性,较中等潮气量为低确定性;俯卧位通气较中等潮气量为高确定性,较低潮气量为中等确定性;VV-ECMO与俯卧位通气比较为极低确定性。
- 局限:VV-ECMO与俯卧位通气的比较仅基于间接比较,置信区间很宽,确定性极低。
对床旁实践的改变
- 在成人重度ARDS(PaO2/FiO2<80 mmHg)中,俯卧位通气有中至高等确定性证据支持降低死亡率,可优先于单纯调整潮气量策略施行。
- VV-ECMO在低至中等确定性证据下较低或中等潮气量通气降低死亡率,可作为考虑选项。
- VV-ECMO与俯卧位通气之间的选择仍不确定,因仅基于间接比较且置信区间很宽。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: Severe acute respiratory distress syndrome (ARDS) with PaO2/FiO2 < 80 mmHg is a life-threatening condition. The optimal management strategy is unclear. The aim of this meta-analysis was to compare the effects of low tidal volumes (Vt), moderate Vt, prone ventilation, and venovenous extracorporeal membrane oxygenation (VV-ECMO) on mortality in severe ARDS.
METHODS: We performed a frequentist network meta-analysis of randomised controlled trials (RCTs) with participants who had severe ARDS and met eligibility criteria for VV-ECMO or had PaO2/FiO2 < 80 mmHg. We applied the Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) methodology to discern the relative effect of interventions on mortality and the certainty of the evidence.
RESULTS: Ten RCTs including 812 participants with severe ARDS were eligible. VV-ECMO reduces mortality compared to low Vt (risk ratio [RR] 0.77, 95% confidence interval [CI] 0.59-0.99, moderate certainty) and compared to moderate Vt (RR 0.75, 95% CI 0.57-0.98, low certainty). Prone ventilation reduces mortality compared to moderate Vt (RR 0.78, 95% CI 0.66-0.93, high certainty) and compared to low Vt (RR 0.81, 95% CI 0.63-1.02, moderate certainty). We found no difference in the network comparison of VV-ECMO compared to prone ventilation (RR 0.95, 95% CI 0.72-1.26), but inferences were based solely on indirect comparisons with very low certainty due to very wide confidence intervals.
CONCLUSIONS: In adults with ARDS and severe hypoxia, both VV-ECMO (low to moderate certainty evidence) and prone ventilation (moderate to high certainty evidence) improve mortality relative to low and moderate Vt strategies. The impact of VV-ECMO versus prone ventilation remains uncertain.
参考来源
- Sud S, Fan E, Adhikari NKJ, et al. Comparison of venovenous extracorporeal membrane oxygenation, prone position and supine mechanical ventilation for severely hypoxemic acute respiratory distress syndrome: a network meta-analysis. Intensive Care Med. 2024. PMID: 38842731. doi:10.1007/s00134-024-07492-7
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。